PHILADELPHIA — The University of Pennsylvania’s Institute for Translational Medicine and Therapeutics’ (ITMAT) 11th Annual International Symposium will cover precision medicine research in academic medical centers and biotech. Speakers will include experts in precision medicine, epigenetics, global health, and microbiome biology.
Date: Monday and Tuesday, October 17-18, 2016, starting at 8:00 am.
Location: Smilow Center for Translational Research, Rubenstein Auditorium and Lobby, 3400 Civic Center Blvd, Philadelphia, PA 19104
Additional details:
The symposium will feature presentations in seven major areas:
- Precision Medicine at Scale
- The Biology of Senescene
- Precision in Cardiovascular Biology
- Chasing Precision in Cancer
- Immunometabolism and Cancer
- Personalized Paradigms in Diagnosis and Therapeutics
- Parsing the Microbiome
Garret A. FitzGerald, MD, FRS, director of ITMAT, will host the event. Speakers and talks include:
- Precision Medicine and Global Health, Ezekiel J. Emanuel, MD, PhD, Vice Provost for Global Initiatives, Chair, Department of Medical Ethics and Health Policy, University of Pennsylvania
- Epigenetic Biomarkers of Aging and Applications, Steve Horvath, PhD, ScD, Professor, Department of Human Genetics, University of California, Los Angeles
- Correction of Duchenne Muscular Dystrophy by Genome Editing, Eric Olson, PhD, Professor and Chairman, UT Southwestern Medical Center
- Precision Guiding T Cells: Lessons from Scaling to the Masses, Carl June, MD, Richard Vague Professor in Immunotherapy, Perelman School of Medicine, University of Pennsylvania
- Hypoxia, Metabolism, and Tumor Progression, M. Celeste Simon, PhD, Scientific Director and Investigator, Abramson Family Cancer Research Institute; Professor, Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania
- Wearable Sweat Sensors for Instantaneous Health Monitoring, Ali Javey, PhD, Conexant Systems Distinguished Professor, Electrical Engineering and Computer Sciences, Applied Science and Technology, University of California, Berkeley
For additional details and presentation times, visit the 2016 Agenda.
Registration is required for attendance and for participation via web:
If you plan to attend, please register and RSVP to Karen Kreeger at Karen.kreeger@uphs.upenn.edu.
Funding for this conference was made possible in part from the journal Science Translational Medicine.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.